chromane compounds (Shenyang Pharmaceutical University)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug Namechromane compounds (Shenyang Pharmaceutical University)
Drug Alias NameHEF-05HEF-19
ClassificationSmall molecules
Mechanisms of ActionVoltage-gated L-type calcium channel modulatorsPotassium channel modulators
TargetsPotassium channelVoltage-gated L-type calcium channel
Therapy Area/IndicationsGastrointestinal Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaPending
Originator CompaniesShenyang Pharmaceutical University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesShenyang Pharmaceutical University
Active IndicationsN/A
Inactive IndicationsGastrointestinal Diseases

Other Information

ATC CodeN/A
Related LinksN/A